# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $35 to $32.
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $37 to $34.
Deutsche Bank analyst Emmanuel Rosner maintains Adient (NYSE:ADNT) with a Hold and lowers the price target from $32 to $30.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $38 to $33.
Adient Plc shares dip post-Q2 earnings, despite beating adjusted EPS but missing sales estimates, as it lowers FY24 outlook.